MR-compliant content
Every piece of content reviewed against the relevant regulatory framework. India's CDSCO, EU's MDR, US FDA — the rules differ; the discipline doesn't.
Healthcare · MedTech
Marketing that respects the science.
Healthcare and MedTech marketing has a credibility ceiling no other category has. The audience is sceptical. The regulator is watching. The buyer journey is long. The marketing model that works in D2C wellness will get you sued in regulated diagnostics — and the model that works in pharma is overkill for hospital equipment.
0MedTech engagements
0Compliance issues raised
0KOL programmes built
0Lift in distributor leads
The problem
Most healthcare marketing fails because it's marketing-first, not clinically-first.
Marketers used to D2C playbooks see the healthcare audience and overreach — claims that won't survive scrutiny, content that triggers compliance, paid ads that get rejected. The result is brand damage that takes years to repair.
How I help
What you get
Channel by buyer
Hospital procurement is one channel. Specialist physicians are another. Distributors are a third. Patients (where allowed) are a fourth.
KOL programmes
In healthcare, third-party credibility outranks brand voice. KOL programmes — done with integrity — are often the highest-leverage marketing investment.
Export-grade content
India MedTech exporting needs content calibrated for EU/US standards. Different claim language, different evidence depth.
How it works
Operating cadence
Compliance map
Regulatory framework, claim limitations, content review process — defined first.
Channel design
Hospital, specialist, distributor, patient (where allowed). Each its own track.
Content & KOL
Clinically grounded content. KOL identification and programme design.
Run
Weekly review. Lead tracking by channel. Distributor pipeline visibility.
Selected work
Recent engagements
Anonymised at client request — substance unchanged.
MedTech · DistributorIndian medical-devices manufacturer
Healthcare · BrandHospital chain · multi-specialty
Diagnostics · Demand genDiagnostics platform · pan-India
MedTech · ExportMR-compliant device exporter
Pharma-tech · BrandIndia-Europe pharma-adjacent SaaS
Wellness · D2CWellness D2C brand · clinically-grounded
Distributor pipeline
Hospital + distributor leads tracked in Vyndeal.
MedTech selling runs through hospitals and distributors. Sample, demo, evaluation, PO — each stage tracked, GST-compliant quoting built in.
Try Vyndeal freeCompliant content delivery
Quiamo's healthcare desk handles compliant production.
Clinical content writers, MR-aware reviewers, KOL piece producers. The compliance discipline the category demands.
See QuiamoFAQ
Common questions
Do you work with pharma directly?
Pharma-adjacent and MedTech, mostly. True pharma marketing in India is highly regulated and usually run by specialised agencies.
What about D2C health/wellness?
D2C wellness brands are closer to D2C than to MedTech. The maths model applies; claim discipline is still important.
Hospital marketing — is that a thing?
Yes. Hospital chains marketing to patients (especially private/multi-specialty) is a discrete category.
Do you handle the regulatory submission?
No — that's a legal/regulatory affairs function. I work with your team to keep marketing inside the lines they draw.
Can you help with EU/US export marketing?
Yes — Indian MedTech going to EU/US needs different content depth and claim discipline.
Ready to talk?
Book a 30-minute discovery call. We'll work out fit, scope and shape — no deck, no preamble.